• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于条件功效提前停止以接受原假设:近似值与比较

Early stopping to accept H(o) based on conditional power: approximations and comparisons.

作者信息

Betensky R A

机构信息

Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

出版信息

Biometrics. 1997 Sep;53(3):794-806.

PMID:9290216
Abstract

It is intuitively appealing to clinicians to stop a trial early to accept the null hypothesis Ho if it appears that this will be the likely outcome at the planned end of the trial. We consider procedures that calculate at each time point the conditional probability of rejecting Ho at the end of the trial given the current data and some value of the parameter of interest. Lan, Simon, and Halperin (1982, Communications in Statistics C1, 207-219) calculate this probability under the design alternative, and Pepe and Anderson (1992, Applied Statistics 41, 181-190) use an alternative based solely on the current data. We investigate a modification to Pepe and Anderson's (1992) procedure that has a more satisfying interpretation. We define all of these procedures as formal sequential tests with lower stopping boundaries and study them in this context. This facilitates an improved understanding of the interplay of parameters by introducing visual displays, and it leads to an approximation for power by treating it as a boundary crossing probability. We use these tools to compare the performances of the different designs under a variety of parameter configurations.

摘要

对于临床医生来说,如果在试验计划结束时似乎零假设(H_0)很可能成立,那么提前终止试验以接受零假设(H_0)在直觉上很有吸引力。我们考虑这样的程序,即在每个时间点计算给定当前数据和感兴趣参数的某个值时在试验结束时拒绝(H_0)的条件概率。Lan、Simon和Halperin(1982年,《统计通信》C1,207 - 219)在设计备择假设下计算此概率,而Pepe和Anderson(1992年,《应用统计学》41,181 - 190)使用仅基于当前数据的一种方法。我们研究对Pepe和Anderson(1992年)程序的一种修改,这种修改具有更令人满意的解释。我们将所有这些程序定义为具有较低停止边界的形式化序贯检验,并在此背景下对它们进行研究。通过引入可视化展示,这有助于更好地理解参数之间的相互作用,并且通过将检验功效视为边界穿越概率,从而得到检验功效的近似值。我们使用这些工具在各种参数配置下比较不同设计的性能。

相似文献

1
Early stopping to accept H(o) based on conditional power: approximations and comparisons.基于条件功效提前停止以接受原假设:近似值与比较
Biometrics. 1997 Sep;53(3):794-806.
2
Multiple imputation for early stopping of a complex clinical trial.用于复杂临床试验提前终止的多重填补法。
Biometrics. 1998 Mar;54(1):229-42.
3
A review of methods for futility stopping based on conditional power.基于条件功效的无效性终止方法综述。
Stat Med. 2005 Sep 30;24(18):2747-64. doi: 10.1002/sim.2151.
4
Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.基于序贯条件概率比检验和反向随机截尾的临床试验设计。
Biometrics. 1998 Jun;54(2):682-95.
5
Design and analysis of group sequential logrank tests in maximum duration versus information trials.最大持续时间与信息量试验中序贯对数秩检验的设计与分析
Biometrics. 1995 Sep;51(3):988-1000.
6
Optimal conditional error functions for the control of conditional power.用于控制条件功效的最优条件误差函数。
Biometrics. 2004 Sep;60(3):715-23. doi: 10.1111/j.0006-341X.2004.00221.x.
7
Operating characteristics of sample size re-estimation with futility stopping based on conditional power.基于条件把握度进行无效性终止的样本量重新估计的操作特征
Stat Med. 2006 Oct 15;25(19):3348-65. doi: 10.1002/sim.2455.
8
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.
9
Conditional power calculations for early acceptance of H0 embedded in sequential tests.序贯检验中用于提前接受原假设H0的条件功效计算。
Stat Med. 1997 Feb 28;16(4):465-77. doi: 10.1002/(sici)1097-0258(19970228)16:4<465::aid-sim384>3.0.co;2-r.
10
Continuous and group sequential conditional probability ratio tests for phase II clinical trials.用于II期临床试验的连续和序贯条件概率比检验
Stat Med. 1996 Oct 15;15(19):2037-51. doi: 10.1002/(SICI)1097-0258(19961015)15:19<2037::AID-SIM339>3.0.CO;2-Z.

引用本文的文献

1
The utility of Bayesian predictive probabilities for interim monitoring of clinical trials.贝叶斯预测概率在临床试验中期监测中的效用。
Clin Trials. 2014 Aug;11(4):485-493. doi: 10.1177/1740774514531352. Epub 2014 May 28.
2
Three-component cure rate model for nonproportional hazards alternative in the design of randomized clinical trials.三组件非比例风险替代 cure 率模型在随机临床试验设计中的应用。
Clin Trials. 2012 Apr;9(2):155-63. doi: 10.1177/1740774512436614. Epub 2012 Feb 21.